CORRESPONDENCE: LETTER TO THE EDITOR
Coenzyme Q10 in Statin-Associated Myopathy
Harvey Wolinsky, MD, PhD, FACC*
* Clinical Professor of Medicine, Mt. Sinai Medical Center, Department of Medicine, 49 East 96th Street, Suite 1A, New York, New York 10128 (Email: HWolinskymd{at}aol.com).
The excellent review by Macroff and Thompson titled "The role of coenzyme Q10 on statin-associated myopathy" (1) concludes that insufficient evidence exists for supplementation to treat or prevent myopathy.
However, the authors recommend its use "if only via placebo effect." Should we not first be certain that statin-induced inhibition of the farnesyl (and dolichol) pathways does not contribute to the many pleiotropic benefits of statins before we attempt to "correct" them?
 |
References
|
|---|
1. Marcoff L, Thompson PD. The role of coenzyme Q10 in statin-associated myopathy: a systematic review J Am Coll Cardiol 2007;49:2231-2237.[Abstract/Free Full Text]
Related Articles
-
Reply
- Leo Marcoff and Paul D. Thompson
J. Am. Coll. Cardiol. 2007 50: 1911.
[Full Text]
[PDF]
-
Can Critically Short Telomeres Cause Functional Exhaustion of Progenitor Cells in Postinfarction Heart Failure?
- Hisko Oeseburg, B. Daan Westenbrink, Rudolf A. de Boer, Wiek H. van Gilst, Dirk J. van Veldhuisen, and Pim van der Harst
J. Am. Coll. Cardiol. 2007 50: 1911-1912.
[Full Text]
[PDF]
This article has been cited by other articles:
|
|
|
|
 
R. S. Vasan, S. Demissie, M. Kimura, L. A. Cupples, C. White, J. P. Gardner, X. Cao, D. Levy, E. J. Benjamin, and A. Aviv
Association of Leukocyte Telomere Length With Echocardiographic Left Ventricular Mass: The Framingham Heart Study
Circulation,
September 29, 2009;
120(13):
1195 - 1202.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. van der Harst, D. J. van Veldhuisen, and N. J. Samani
Expanding the Concept of Telomere Dysfunction in Cardiovascular Disease
Arterioscler Thromb Vasc Biol,
May 1, 2008;
28(5):
807 - 808.
[Full Text]
[PDF]
|
|
|
|
Top
References